Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

PATENTS

3D and 4D bioprinted human model patenting and the future of drug development

Bioprinted 3D and 4D tissues and organs are expected to revolutionize the biomedical field, eliminating the need for laboratory animals, but little is known about the future impacts of these technologies on drug development.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Networks of technology areas and patent assignees of bioprinting-related patents.
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. 1.

    Doke, S. K. & Dhawale, S. C. Saudi Pharm. J. 23, 223–229 (2015).

    Article  Google Scholar 

  2. 2.

    Graham, M. L. & Prescott, M. J. Eur. J. Pharmacol. 759, 19–29 (2015).

    CAS  Article  Google Scholar 

  3. 3.

    Cheluvappa, R., Scowen, P. & Eri, R. Pharmacol. Res. Perspect. 5, e00332 (2017).

    Article  Google Scholar 

  4. 4.

    Fleetwood, G. et al. J. Am. Assoc. Lab. Anim. Sci. 54, 192–197 (2015).

    PubMed  PubMed Central  Google Scholar 

  5. 5.

    Vanderburgh, J., Sterling, J. A. & Guelcher, S. A. Ann. Biomed. Eng. 45, 164–179 (2017).

    Article  Google Scholar 

  6. 6.

    Goh, J.-Y. et al. Toxicol. Res. 4, 1297–1307 (2015).

    CAS  Article  Google Scholar 

  7. 7.

    Stokes, W. S. Hum. Exp. Toxicol. 34, 1297–1303 (2015).

    CAS  Article  Google Scholar 

  8. 8.

    Groeber, F. et al. ALTEX 33, 415–422 (2016).

    PubMed  Google Scholar 

  9. 9.

    Burden, N. et al. Nano Today 12, 10–13 (2017).

    CAS  Article  Google Scholar 

  10. 10.

    Löwa, A., Jevtić, M., Gorreja, F. & Hedtrich, S. Exp. Dermatol. 27, 476–483 (2018).

    Article  Google Scholar 

  11. 11.

    Rosania, K. Lab. Anim. 42, 189–190 (2013).

    Article  Google Scholar 

  12. 12.

    Kim, K., Park, H. & Lim, K.-M. Toxicol. Res. 31, 97–104 (2015).

    CAS  Article  Google Scholar 

  13. 13.

    Ford, K. A. ILAR J. 57, 226–233 (2016).

    CAS  Article  Google Scholar 

  14. 14.

    Atala, A. & Yoo, J. J. Essentials of 3D Biofabrication and Translation (Elsevier Science, 2015).

  15. 15.

    Peng, W. et al. Acta Biomater. 57, 26–46 (2017).

    CAS  Article  Google Scholar 

  16. 16.

    Brown, G. E. & Khetani, S. R. Philos. T. R. Soc. B 373, e2017.0225 (2018).

    Article  Google Scholar 

  17. 17.

    Ahn, S. H. et al. J. Tissue Eng. Regen. Med. 13, 663–676 (2016).

    CAS  Article  Google Scholar 

  18. 18.

    Gao, G. & Cui, X. Biotechnol. Lett. 38, 203–211 (2016).

    CAS  Article  Google Scholar 

  19. 19.

    Huang, Y. et al. Biotechnol. J. 12, 1600734 (2017).

    Article  Google Scholar 

  20. 20.

    Hunsberger, J. et al. Curr. Stem Cell Rep. 2, 118–127 (2016).

    CAS  Article  Google Scholar 

  21. 21.

    Yang, G. H., Yeo, M., Koo, Y. W. & Kim, G. H. Macromol. Biosci. 19, e1800441 (2019).

    Article  Google Scholar 

  22. 22.

    Ashammakhi, N. et al. Biotechnol. J. 13, e1800148 (2018).

    Article  Google Scholar 

  23. 23.

    Mammadov, E. Cyprus J. Med. Sci. 3, 186–188 (2018).

    Article  Google Scholar 

  24. 24.

    Moldovan, N. I. J. Cell. Mol. Med. 22, 2964–2969, https://doi.org/10.1111/jcmm.13598 (2018).

    Article  Google Scholar 

  25. 25.

    Awad, A., Trenfield, S. J., Goyanes, A., Gaisford, S. & Basit, A. W. Drug Discov. Today 23, 1547–1555 (2018).

    CAS  Article  Google Scholar 

  26. 26.

    Charbe, N., McCarron, P. A. & Tambuwala, M. M. World J. Clin. Oncol. 8, 21–36 (2017).

    Article  Google Scholar 

  27. 27.

    Mazzocchi, A., Soker, S. & Skardal, A. Appl. Phys. Rev. 6, 11302 (2019).

    Article  Google Scholar 

  28. 28.

    Drăgănescu, D. Farmacia 67, 1–9 (2019).

    Article  Google Scholar 

  29. 29.

    Lerman, M. J. et al. Appl. Phys. Rev. 5, 41109 (2018).

    Article  Google Scholar 

  30. 30.

    Kačarević, Ž. P. et al. Materials (Basel) 11, 2199 (2018).

    Article  Google Scholar 

  31. 31.

    Jang, J., Yi, H.-G. & Cho, D.-W. ACS Biomater. Sci. Eng. 2, 1722–1731 (2016).

    CAS  Article  Google Scholar 

  32. 32.

    European Parliament. Regulation (eu) no 575/2013 of the European Parliament and of the Council. OJEU 176, 1–337 (2013).

    Google Scholar 

  33. 33.

    USDA. Animal Welfare Act and Animal Welfare Regulations (USDA, 2017).

  34. 34.

    Frank, J. Struct. Change Econ. Dyn. 16, 557–575 (2005).

    Article  Google Scholar 

  35. 35.

    Herrmann, K. (ed.). Animal Experimentation: Working Towards a Paradigm Change (Brill, 2019).

  36. 36.

    Ngo, T. D. et al. Compos. B Eng. 143, 172–196 (2018).

    CAS  Article  Google Scholar 

  37. 37.

    Ma, X. et al. Adv. Drug Deliv. Rev. 132, 235–251 (2018).

    CAS  Article  Google Scholar 

  38. 38.

    Bhanu, P. C. H. Transl. Biomed. 7, 4 (2016); https://doi.org/10.2167/2172-0479.100099

  39. 39.

    Peng, W., Unutmaz, D. & Ozbolat, I. T. Trends Biotechnol. 34, 722–732 (2016).

    CAS  Article  Google Scholar 

  40. 40.

    Mohammadi, M. H., Obregón, R., Ahadian, S., Ramón-Azcón, J. & Radisic, M. Curr. Pharm. Des. 23, 2991–3004 (2017).

    CAS  Article  Google Scholar 

  41. 41.

    Haque, S., Md, S., Whittaker, M. & Kaminskas, L. M. Curr. Pharm. Des. 24, 5072–5080 (2018).

    CAS  Article  Google Scholar 

Download references

Acknowledgements

The authors thank the Center for Strategic Studies of Oswaldo Cruz Foundation (CEE-Fiocruz) for institutional support and the respondents who participated in this study. This study was supported by research funds from Inova Fiocruz/Fundação Oswaldo Cruz.

Author information

Affiliations

Authors

Contributions

F.M. designed, planned, coordinated and analyzed the work and revised the paper. L.B. reviewed the literature, interpreted results and wrote the paper. L.R. analyzed and evaluated statistical data and graphs and described results. B.C. organized and conducted the survey protocol and revised the final paper. All authors approved the submitted final version.

Corresponding author

Correspondence to Fabio Mota.

Ethics declarations

Competing interests

The authors declare no competing interests.

Supplementary information

Supplementary Information

Supplementary Tables 1 and 2 and Appendixes A and B

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mota, F., Braga, L., Rocha, L. et al. 3D and 4D bioprinted human model patenting and the future of drug development. Nat Biotechnol 38, 689–694 (2020). https://doi.org/10.1038/s41587-020-0540-1

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing